Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: It is well known that patients with endogenous Cushing's syndrome (CS) have decreased bone mass and enhanced risk for osteoporotic fractures, secondary to decreased bone formation and increased bone resorption. Immunological mediators, such as cytokines, have recently been shown to influence bone metabolism, and in the present study we examined serum levels of several cytokines, with known or potential effects on bone homeostasis, in 33 consecutive recruited untreated CS patients and 33 age-, sex- and body mass index-matched healthy controls. METHODS: Cytokine levels were measured by enzyme immunoassay and bone mass by dual-energy X-ray absorptiometry. RESULTS: Our main findings were (i) interleukin (IL)-8 and IL-18 levels were significantly increased in CS patients compared with controls. (ii) Levels of both IL-8 and IL-18 were positively correlated to serum cortisol. (iii) For serum levels of the 'classical' resorptive cytokines, i.e. IL-6 and tumor necrosis factor alpha, no significant differences were found between CS patients and controls. (iv) Raised IL-18 levels were correlated with decreased osteocalcin levels in CS patients. CONCLUSIONS: Our results demonstrated that CS patients have markedly elevated levels of the proinflammatory cytokines IL-8 and IL-18 in spite of high levels of the immunosuppressive hormone cortisol. These cytokines may be involved in the pathogenesis of disturbed bone homeostasis in CS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A high level of glucocorticoid in smokers alters bone metabolism and decreases bone mass either directly by changing the osteoblast and osteoclast activities or indirectly by altering the gastrointestinal absorption and renal reabsorption of calcium [39–42].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [41]
Citations
Cites
IL-6 is produced by osteoblasts and induces bone resorption.
Ishimi, Y., Miyaura, C., Jin, C. H., Akatsu, T., Abe, E., Nakamura, Y., Yamaguchi, A., Yoshiki, S., Matsuda, T., Hirano, T., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3297 · Cited by 1,128
IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 family
Dinarello, C. A. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70518-x · Cited by 819 · cited 2×
“IL-18, originally identified as interferon g-inducing factor, is related to the IL-1 family in terms of its structure, processing, receptor, signal transduction pathway and proinflammatory properties ( 25 , 27) but, in contrast to the resorptive abilities of IL-1b, the effects of IL-18 seem to be bone protective; firs…”
BackgroundEstrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Pacifici, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110802 · Cited by 741
Canalis, E. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3441 · Cited by 463 · cited 2×
“To some degree most patients with CS have hypogonadotropic hypogonadism, either directly because of the pituitary adenoma in Cushing’s disease, or indirectly related to inhibition of gonadotropins by glucocorticoid ( 6 ).”
BackgroundUdagawa, N., Horwood, N. J., Elliott, J., Mackay, A., Owens, J., Okamura, H., Kurimoto, M., Chambers, T. J., Martin, T. J., & Gillespie, M. T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.6.1005 · Cited by 378 · cited 1×
“However, both IL-8 and IL-18 can be produced by osteoblasts ( 28 , 29) and IL-8 by osteoclasts in response to proinflammatory stimuli (2).”
Role of cytokines in bone resorption
Manolagas, S. C. (1995) · Bone · doi:10.1016/8756-3282(95)00180-l · Cited by 312 · cited 1×
“Estrogens inhibit IL-6 and loss of this sex steroid may cause an upregulation of IL-6 production which, in turn, may result in enhanced bone resorption ( 14 ).”
BackgroundAukrust, P., Haug, C. J., Ueland, T., Lien, E., Müller, F., Espevik, T., Bollerslev, J., & Frøland, S. S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5417 · Cited by 182
Self-citationJournal of Bone and Mineral Research
Mundy, G. R. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650081315 · Cited by 178 · cited 1×
“IL-6 and TNFa) ( 11 , 12, 26), but few studies have addressed the role of IL-8 and IL-18 in this process (26, 27).”
BackgroundChiodini, I. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.1863 · Cited by 153 · cited 1×
“Secondary osteoporosis is a major problem in several endocrine and chronic inflammatory disorders, but the pathogenic mechanisms have been only partly elucidated (1 ‐ 3). Among others, we have recently shown that bone mass as well as bone area are reduced in endogenous Cushing’s syndrome (CS), most probably related to…”
BackgroundAukrust, P., Lien, E., Kristoffersen, A., Muller, F., Haug, C., Espevik, T., & Froland, S. (1996) · Blood · doi:10.1182/blood.v87.2.674.bloodjournal872674 · Cited by 152
Self-citationNormal bone mineral density following cure of Cushing's syndrome
Manning, P. J., Evans, M. C., & Reid, I. R. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01437.x · Cited by 146 · cited 1×
“Secondary osteoporosis is a major problem in several endocrine and chronic inflammatory disorders, but the pathogenic mechanisms have been only partly elucidated (1 ‐ 3). Among others, we have recently shown that bone mass as well as bone area are reduced in endogenous Cushing’s syndrome (CS), most probably related to…”
BackgroundBonde, M., Garnero, P., Fledelius, C., Qvist, P., Delmas, P. D., & Christiansen, C. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.7.1028 · Cited by 133 · cited 1×
“The assay measures intact osteocalcin 1 ‐ 49. Degradation products of the C-terminal telopeptides of type I collagen (CTX-1) were measured in serum with a commercial enzyme immunoassay (EIA; Crosslaps) ( 19 ) from Osteometer Bio-Tech A/S, Herlev, Denmark.”
MethodInterleukins in the Control of Osteoclast Differentiation
Martin, T. J., Romas, E., & Gillespie, M. T. (1998) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v8.i2.10 · Cited by 110
Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women
Mckane, W. R., Khosla, S., Peterson, J. M., Egan, K., & Riggs, B. L. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090821 · Cited by 105
Rothe, L., Collin-Osdoby, P., Chen, Y., Sunyer, T., Chaudhary, L., Tsay, A., Goldring, S., Avioli, L., & Osdoby, P. (1998) · Endocrinology · doi:10.1210/endo.139.10.6247 · Cited by 103 · cited 2×
“Furthermore, although IL-1b and TNFa have been suggested to induce bone disturbances in various disorders ( 2 , 22), we found no elevation in serum levels of these ‘classical’ resorptive cytokines in CS patients.”
BackgroundHarper, K. D., & Weber, T. J. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70008-6 · Cited by 99
Circulating cytokine levels in osteoporotic and normal women
Khosla, S. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.3.707 · Cited by 99
Bone and Cytokines: Beyond IL-1, IL-6 and TNF-α
Rifas, A. (1999) · Calcified Tissue International · doi:10.1007/s002239900570 · Cited by 98
Interleukin-18 Up-Regulates Osteoprotegerin Expression in Stromal/Osteoblastic Cells
Makiishi-Shimobayashi, C., Tsujimura, T., Iwasaki, T., Yamada, N., Sugihara, A., Okamura, H., Hayashi, S., & Terada, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4380 · Cited by 92 · cited 1×
“granulocyte macrophage colony-stimulating factor (29), but also by upregulating osteoblastic production of osteoprotegerin ( 31 ).”
BackgroundThe cell biology of bone growth.
Price, J. S., Oyajobi, B. O., & Russell, R. G. G. (1994) · PubMed · Cited by 91
Interleukin-18: Perspectives on the Newest Interleukin
Gillespie, M. T., & Horwood, N. J. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00004-5 · Cited by 83
Godang, K., Ueland, T., & Bollerslev, J. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410126 · Cited by 64 · cited 6×
“Secondary osteoporosis is a major problem in several endocrine and chronic inflammatory disorders, but the pathogenic mechanisms have been only partly elucidated (1 ‐ 3). Among others, we have recently shown that bone mass as well as bone area are reduced in endogenous Cushing’s syndrome (CS), most probably related to…”
BackgroundMethodInfluentialSelf-citationPasseri, G., Girasole, G., Manolagas, S. C., & Jilka, R. L. (1994) · Bone and Mineral · doi:10.1016/s0169-6009(08)80149-3 · Cited by 52
Conti, B., Sugama, S., Kim, Y., Tinti, C., Kim, H., Baker, H., Volpe, B., Attardi, B., & Joh, T. (2000) · Neuroimmunomodulation · doi:10.1159/000026445 · Cited by 48 · cited 2×
“Although the biological significance of these correlations between high levels of cortisol and IL-8 and IL-18 is at present unclear, it may possibly suggest that some immunopathogenic mechanisms may be operating in CS ( 24 , 25).”
BackgroundBoonen, S., Broos, P. L. O., Verbeke, G. N., Aerssens, J., Herck, E. V., Jans, I., Dequeker, J., & Bouillon, R. (1997) · The Journals of Gerontology Series A · doi:10.1093/gerona/52a.5.m286 · Cited by 32
The release of soluble p55 TNF receptor from U937 cells studied by a new p55 immunoassay
Liabakk, N., Sundan, A., Lien, E., Lægreid, A., Bombara, M. P., Ranges, G. E., & Espevik, T. (1993) · Journal of Immunological Methods · doi:10.1016/0022-1759(93)90116-o · Cited by 31 · cited 1×
“Serum levels of soluble TNF receptors (sTNFRs), p55 and p75, were analyzed by EIAs (detection limit between 150 ‐ 300 pg/ml) as described by Liabakk et al. ( 21 ) Intra- and interassay coefficients of variation were ,10% for all assays.”
MethodSelf-citationIncrease in Plasma Interleukin-10 Following Hydrocortisone Injection
Dandona, P., Aljada, A., Garg, R., & Mohanty, P. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5656 · Cited by 29 · cited 1×
“In fact, cortisol administration in vivo has been associated with enhanced levels of the anti-inflammatory cytokine IL-10 and decreased levels of proinflammatory cytokines ( 23 ).”
BackgroundThe Chemokine Interleukin-8 Regulates Parathyroid Secretion
Angeletti, R. H., D'Amico, T., Ashok, S., & Russell, J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.8.1232 · Cited by 20
MASIUKIEWICZ, U. S., & Insogna, K. L. (1998) · Aging Clinical and Experimental Research · doi:10.1007/bf03339657 · Cited by 16
Ueland, T., Frøland, S. S., Bollerslev, J., & Aukrust, P. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00768.x · Cited by 16 · cited 1×
“Systemic and locally produced hormones and growth factors regulate bone metabolism and turnover and recently various cytokines have also been found to be involved in this process ( 9 , 10).”
BackgroundSelf-citation
Cited by
Glucocorticoids and the Th1/Th2 Balance
ELENKOV, I. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.010 · Cited by 612
Bendre, M. S., Montague, D. C., Peery, T., Akel, N. S., Gaddy, D., & Suva, L. J. (2003) · Bone · doi:10.1016/s8756-3282(03)00086-3 · Cited by 428
“with reduced bone mass as well as area, most likely related to decreased bone formation and increased bone resorption via osteoclasts [14].”
BackgroundInfluentialThe effects of smoking on bone metabolism
Yoon, V., Maalouf, N. M., & Sakhaee, K. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1940-y · Cited by 268
Sutinen, E. M., Pirttilä, T., Anderson, G., Salminen, A., & Ojala, J. O. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-199 · Cited by 230
“IL-18 levels are generally increased in Cushing’s disease patients, where a significant positive correlation between IL-18 and cortisol is evident [40].”
BackgroundBertagna, X., Guignat, L., Groussin, L., & Bertherat, J. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.001 · Cited by 222
Metadata
- Authors
- Kristo, C., Godang, K., Ueland, T., Lien, E., Aukrust, P., Froland, S., & Bollerslev, J.
- Affiliations
- Oslo University Hospital (NO)
- Norwegian University of Science and Technology (NO)
- Corresponding author
- Kristo, C
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-03-01
- Volume
- 146
- Issue
- 3
- Pages
- 389-395
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2101972559
- Cited by
- 45
- References
- 30
- Citations by year
- 2026: 2 · 2023: 4 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 7
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- endogenous Cushing's syndrome, interleukin-8, IL-18, bone metabolism, bone homeostasis, inflammatory cytokines, serum cortisol, osteocalcin, bone resorption, bone formation, osteoporosis
- MeSH terms
- Adult, Bone and Bones, Cushing Syndrome, Female, Hormones, Humans, Hydrocortisone, Male, Middle Aged, Biomarkers, Bone Density, Cytokines, Interleukin-8, Interleukin-18
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.